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Garbhini paricharya is advised for preventing harm to mother and fetus, to 
attain full fetal maturity and for normal uneventful labour. By keeping this 
goal in mind the Upakrama of Niruha basti and Anuvasana basti was 
selected. 100 patients were selected for this study and divided into two 
groups. In Control Group, there are 50 patients with Standard 
management (iron+ calcium) with routine diet during pregnancy. In Trial 
Group, there are 50 patients with Standard management (iron+ calcium) 
along with Garbhini paricharya. 
The clinical study was done for evaluation of efficacy of antenatal 
management in Ayurveda during 8th & 9th month of pregnancy. Bala taila 
is highly effective to bring about spontaneous labour onset at optimal 
time. Duration of labour was reduced by Bala siddha taila basti due to its 
regulation of Prasuti Marut. 
Maternal and foetal complications during ante natal and post natal period 
are reduced due to Bala siddha taila Anuvasan basti, Niruha basti and due 
to high quality nutritive supplementation (Mudga & Masha Yavagu). 
Maternal as well as fetal weight gain was good due to high quality 
nutritive supplementation as described in Ayurvedic texts, and it provides 
optimal nutrition of mother and fetus. The Ayurvedic regimen has promise 




Garbhavastha (pregnancy) is a dream way to 
achieve the goal of motherhood. It begins with 
conception and culminates in arrival of lovely human 
being. Garbhavastha is marked by peculiar state of 
Doshas, explained as “Tailamivapoornapatram” in 
Samhitas. It means that Garbhini can land up into 
many complications if she consumes improper diet 
or follows wrong habits (lifestyle). Acharyas have 
recommended Garbhini paricharya (Aahar, Vihar and 
Vichar) to maintain healthy pregnancy and to ensure 
delivery of healthy baby.[1]  
 
Pregnancy and child birth is a turning point 
in a women’s reproductive life. ‘Garbhini’ in our 
science is said to be in a very sensitive state. She is 
compared with a vessel full of oil. [2] 
Aims of Garbhini Paricharya 
1. To minimize maternal and fetal complications 
during pregnancy. 
2. To nourish and develop healthy fetus. 
3. To ensure easy, uneventful labour. 
As the style of living is changing nowadays it 
can have hazardous effects on the health of woman 
and child. In clinical practice many disorders during 
Research Article 
*Address for correspondence 
Dr. Suhas B. Thorat 
Associate Professor,  
Dept. of Stree Rog & Prasuti 
Tantra, Sant Gajanan Maharaj 





Mob. No. 09850366952 
Suhas B. Thorat et al. Efficacy of Antenatal Management in Ayurveda during 8th and 9th Month of Pregnancy 
AYUSHDHARA | March-April 2021 | Vol 8 | Issue 2  3195 
pregnancy and labour arise from lack of proper and 
balanced nutrition. Optimum and balanced maternal 
nutrition is essential for good reproductive 
performance. Selection of patients was done for 8th 
and 9th month Paricharya during this study, which is 
as follows. 
8th month Paricharya: For nourishment of mother 
and development of healthy fetus. Yavagu is Purak or 
supplementary/nutritious diet which helps the 
pregnant woman to remain healthy and ensures 
delivery of the child possessing best health, energy, 
complexion and voice. [3] The last trimester of 
pregnancy belongs to Vata (Vayohoratri bhuktanam, 
Vata dominance). Vitiated Vata can create many 
disorders in Garbha and Garbhini, such as growth 
retardation, prematurity, Moodhagarbha in Garbha 
and APH, PIH, Malavarodh, Udavarta in Garbhini. To 
prevent these conditions Vagbhata 2nd has advised 
Anuvasan basti prepared by using Madhur aushdhi 
Siddha drugs (Bala sidha tail) for evacuation of the 
Puran shakrut. This is followed by Niruha basti made 
from decoction of Shushka muli, Badari and sore 
(Amla) substances mixed with Kalka of Shatpushpa, 
Ghruta, tail and Saindhav. It gives strength to 
Garbhashaya and can prevent preterm labour by 
preventing Udavarta and Akala avi pradurbhava i.e., 
premature contractions/labour. Aasthapan or Niruha 
basti is claimed to have Rasayan or rejuvenation 
properties, so it may help in normalizing the anatomy 
and physiology of reproductive organs for 
preparation of parturition. [4] 
9th month Paricharya: [5] Vayu becomes more active 
in 9th month. Basti is the best mode of treatment for 
Vayu. We used Bala tail for Anuvasan Basti which had 
effects like Vatshaman, Vatanuloman & Snehan 
(emollition) of Apatyapath therefore can be helpful 
for Sukhaprasav. [6] Long Chain Polyunsaturated Fatty 
Acids (LCPUFA) is major component of cellular 
membrane and has vital functions in every metabolic 
function in the body. PUFA are vitally important 
structural element of cell membranes and therefore 
essential for the formation of new tissue which 
occurs during pregnancy and fetal development. In 
3rd trimester of pregnancy and during early 
childhood, the brain has its growth spurt. Therefore 
an appropriate pre and post natal supply of PUFA is 
thought to be essential for normal fetal and neonatal 
brain growth, neurological function & development, 
the activity of retinal photoreceptors and learning 
and behavior.  
 
 
AIM AND OBJECTIVES 
Aim: Efficacy of antenatal management in Ayurveda 
during 8th and 9th month of pregnancy. 
Objectives 
 To study efficacy of Masha and Mudga yavagu on 
fetal nutrition in 8th and 9th month of pregnancy. 
 To study efficacy of Asthapan Basti in 8th month of 
pregnancy. 
 To study efficacy of Bala siddha Tail Anuvasan 
Basti in 8th and 9th month of pregnancy on 
reproductive performance (Mode of delivery, 
Baby weight, any other complications). 
 To study effect of this part of Garbhini paricharya 
on biochemical estimation (LCPUFA levels). 
 Literary review of Garbhini Dietary Habits. 
MATERIALS AND METHODS 
Materials & Dravya Vichar 
 The drug Bala siddha tail was taken from reputed 
local Pharmaceutical Company. 
 The Mudga and Mash Yavagu were prepared by 
standard method mentioned in Sharangadhar 
Samhita and explained to all trial group patients. 
 No objection and ingredient certificates were 
obtained from pharmacy. 
 Authentication of the drugs was done from 
authorized centre. 
Yavagu 
Drug: Mudga (Seed) - (Vigna Radiata) 
Drug: Mash (Seed) - (Teramnus labialis) 
Niruha Basti 
Eliminates Dosha from the body, increase the 
strength of the body or Spreads the potency of the 
drug in the body due to the Prabhava. [7] 
Kwath (Decoction) of Shushka muli, Badar, 
Amla Padartha, with Kalka of Shatpushpa and Ghruta, 
Tail, Saindhav.  
Anuvasan Basti 
Drug: Bala siddha taila 
Yavagu: According to Sharangadhar, 64 Palas of 
water is added to 16 Tolas of rice or barley, boiled 
and reduced to half quantity, and then the 
preparation is called as Yavagu. 
Niruha Basti 
 Kwath (decoction) of Shushka muli, Badar, Amla 
padartha, with Kalka of Shatpushpa and Ghruta, 
tail, Saindhav. 
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Table 1: 8th & 9th Month Garbhini Paricharya Advised regimen by Samhitas[1] 
No. of month Charaka Sushruta Vagbhata 




Ghritayukta ksheer peya madhur-dravya Siddha ghrita-
anuvasana & Niruha of Mulak badar shatahva etc. [9] 
9th Anuvasan basti 
pichu [10] 
Asthapna Basti 
Anuvasan Basti[11]  
Mansarsa, Snehayukta yavagu, Anuvasana, Pichu[12] 
Table2: Drugs of Niruha basti 
Drug’s Name Latin Name Quantity 
Shushka mulak Raphanus sativus Linn 25gm 
Badar Zizyphus mauritiana Lam 25gm 
Amalaki Emblica officinalis 25gm 
Shatapushpa Anethum sowa kruz 3gm 
Til Tail (Sesame Oil) Sesamum Indicam 30ml 
Goghrit Cows ghee  3gm 
Saindhav Rock salt 3gm 
Madhu Honey 10gm 
Requirement/Equipment 
Enema can, rubber catheter, prescribed medicine (contents of Niruha Basti), water bath, cloth for 
draping, towel for fomentation, oil for Abhyanga, hand gloves.  
Preparation of the Medicine  
The medicine used in Niruha Basti consists of following ingredients Shushka mulak, Badar, Amalaki, 
Shatapushpa, Til Tail, Goghrit, Saindhav, and Madhu. 
Method of Preparation 
Step 1- 3gm of Saindhavlavan and 10gm of Madhu mix together and then Sneha i.e. Gogrut (3 gms appx 5ml) + 
Til tail (30ml) in a clean and dry container. 
Step 2-Add Kalka of Shatpushpa (3gs). 
Step 3- At the end mix Kwath of Badar (25gm), Amalaki (25gm) and Shushka- mulak (25gm).  
Step 4- Mix all the drugs thoroughly. 
Step 5- This whole mixture emulsified with churner or electronic mixer.  
Before last the properly mixed combination of this medicine is heated to make it lukewarm. 
Selection of Patients 
Inclusion Criteria  
1. Primi Para 
2. Who are already registered in this study from 2nd month of pregnancy 
Exclusion Criteria 
1. Present pregnancy with chronic illness viz. PIH, G.D.M., Heart disease. 
Study Design 
Number of Patients: Total 100 pt. were studied in two groups. 
Control Group: 50 patients with Standard management (iron+ calcium) with routine diet during pregnancy. 
Trial Group: 50 patients with Standard management (iron+ calcium) + Garbhini paricharya which are 
mentioned. 
Assessment Parameters: The efficacy of the drug was judged on the following parameters- 
1) Maternal weight gain 
2) Foetal weight by USG 
3) Garbhashaya vruddhi (Fundal height) 
4) Abdominal girth (at umbilicus) 
5) Foetal weight record 
6) Neonatal weight 
7) Mode of delivery 
8) Onset of labour 
9) Labour progress- according to partogram 
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10)  Augmentation required or not required 
11)  Total duration of labour 
Investigations 
1. Routine investigations of Garbhini (Haemogram, Blood Group, BSL(R), HIV, VDRL, HbsAg, Urine R/M.) 
2. USG (trimester wise) 
3. Oxidative stress 
4. Plasma long chain polyunsaturated fatty acids levels (Plasma PUFA) 
5. Erythrocyte long chain polyunsaturated fatty acids levels (LCPUFA) 
6. Placental long chain polyunsaturated fatty acids levels (Placental PUFA) 
7. Lactational long chain polyunsaturated fatty acids levels (Lactation PUFA)  
Place of Work 
Clinical work: OPD in Bharati Ayurved Hospital 
Laboratory work: Interactive Research School of Health Affairs (IRSHA) 
Statistical Method 
 Appropriate statistical method was used. ‘Z’ test was used. 
Observations and Statistical Analysis 
Observations were represented with the help of various tables and graphs. Statistical analysis was done 
by SPSS software version 10 (t, and Wilcoxan sign rank test) and statistical significance was set at P < 0.05. 
Table 3: Age 
Age (yrs.) Trial Control 
18 to 21 yrs 32 30 
upto 24 yrs 14 15 
upto 27 yrs 4 3 
upto 30 yrs 0 2 
Total 50 50 
Age (%) Trial (%) Control (%) 
18 to 21 yrs 64.00 60.00 
upto 24 yrs 28.00 30.00 
upto 27 yrs 8.00 6.00 
upto 30 yrs 0.00 4.00 
Total 100.00 100.00 
The age wise distribution shows that maximum volunteers were belonging to the age group 18-21 yrs. 
Only primi para were selected as volunteers. 2 volunteers from control group were between 28- 30 yrs.  
Table 4: Occupation 
Occupation Trial Control 
Housewife 35 42 
Working 3 2 
Students 12 6 
Total 50 50 
Occupation (%) Trial (%) Control (%) 
Housewife 70.00 84.00 
Working 6.00 4.00 
Students 24.00 12.00 
Total 100.00 100.00 
Distribution in this study based on occupation shows that almost all the cases were housewives. 
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Table 5: Socio-Economic Status 
Socio-Economic Status Trial Control 
Low class 31 22 
Middle class 18 25 
High class 1 3 
Total 50 50 
Socio-Economic Status Trial (%) Control (%) 
Low class 62.00 44.00 
Middle class 36.00 50.00 
High class 2.00 6.00 
Total 100.00 100.00 
Distribution of economic status shows that the cases from trial group were almost lower class.  
Table 6: Katishool 
Katishool 
Present 
Before Treatment After Treatment 
Trial 25 3 
Control 20 14 




SE Applied Test Z score Significance 
Katishool 0.320 0.0898 Z test for proportion 3.563 Significant 
The table shows the statistical analysis for Katishool in two different groups, where the Z score shows 
the difference is significant at the end of study. There is significant difference in Katishool in trial group as 
compared to control group. 
Table 8: Adhodarshool 
Adhodarshool 
Present 
Before Treatment After Treatment 
Trial 11 5 
Control 16 11 




SE Applied Test Z score Significance 
Adhodarshool 0.020 0.0626 Z test for proportion 0.3200 Not Significant 
The table shows the statistical analysis for improvement in Adhodarshool in two different groups, where 
the Z score shows the difference is not significant at the end of study. There is no significant difference in 
Adhodarshool in both groups.  
Table 10: Malavashtambh 
Malavashtambh 
Present 
Before Treatment After Treatment 
Trial 13 3 
Control 20 11 
Table 11: Statistical Analysis for change in Malavashtambh in two groups 
Variable Proportion difference SE Applied Test Z score Significance 
Malavashtambh 0.020 0.0785 Z test for proportion 0.2549 Not Significant 
The table shows the statistical analysis for Malavashtambh in two different groups, where the Z score 
shows the difference is not significant at the end of study. It means that there is no significant difference in 
Malavashtambh in both groups. 
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Table 12: Onset of Labour 
Onset of labour% Induced Spontaneous 
Trial 16 84 
Control 54 46 
Table 13: Statistical Analysis for change in Onset of Labour in two groups 
Variable Proportion difference SE Applied Test Z score Significance 
Onset of Labour 0.38 0.0954 Z test for proportion 3.983 Significant 
The table shows the statistical analysis for Onset of Labour in two different groups, where the Z score 
shows the difference is significant. It means that there is significant increase in spontaneous Onset of Labour in 
trial group as compared to control group. 
Table 14: Need for Augmentation 
Need of augmentation % Yes No 
Trial 24 76 
Control 80 20 















The table shows the statistical analysis of Need for Augmentation in two different groups, where the Z 
score shows the difference is significant. It means that there is significantly less Need for Augmentation in trial 
group as compared to control group.  
Table 16: Partogram Curve 
Partogram Curve% Abnormal Normal 
Trial 26 74 
Control 72 28 




SE Applied Test Z score Significance 
Partogram Curve 0.46 0.0999 Z test for proportion 4.601 Significant 
The table shows the statistical analysis for Partogram Curve in two different groups, where the Z score 
shows the difference is significant. It means that there is significant difference in Partogram Curve in trial group 
as compared to control group.  
Table 18: Total Duration of Labour 
Total duration of Labour% More than 12 hrs. Less than 12 hrs. 
Trial 12 88 
Control 64 36 




SE Applied Test Z score Significance 
Total duration of 
Labour 
0.52 0.0971 Z test for proportion 5.357 Significant 
 The table shows statistical analysis for Total duration of Labour in two different groups, where the Z 
score shows the difference is significant. It means that there is significant difference in Total duration of Labour 
in trial group as compared to control group.  
Table 20: Increase in Weight of the Patients 
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Table 21: Statistical Analysis for change in Patients’ Weight in two groups 
Variable Mean difference SE Applied Test Z score Significance 
Patients’ Weight 0.76 0.13 Z test for mean 6.00 Significant 
The table shows statistical analysis for increase in Patients Weight in two different groups, where the Z 
score shows the difference is significant at the end of study. It means that there is significant increase in 
Patients Weight in trial group as compared to control group.  
Table 22: Increase in Fetal Weight 
Average increase in Fetal Weight in gms. 
Trial 1833.78 
Control 1532.40 
Table 23: Statistical Analysis for change in Fetal Weight in two groups 
Variable Mean difference SE Applied Test Z score Significance 
Fetal Weight 301.38 62.70 Z test for Mean 4.81 Significant 
The table shows statistical analysis for improvement in Infant Weight in two different groups, where 
the Z score shows the difference is significant at the end of study. It means that there is significant increase in 
Fetal Weight in trial group as compared to control group.  
Table 24: Birth Weight 
Average Birth Weight in gms. 
Trial 3158.80 
Control 2712.00 




SE Applied Test Z score Significance 
Birth Weight 446.80 78.09 Z test for Mean 5.72 Significant 
The table shows the statistical analysis for Birth Weight in two different groups, where the Z score 
shows the difference is significant at the end of study. It means that there is significant difference to increase in 
Average Birth Weight in trial group as compared to control group. 
Table 26: Mode of Delivery 
Mode of Delivery in % Trial Control 
FTND 66 42 
PTVD 6 6 
PDVD 0 0 
LSCS 28 48 
PTLSCS 0 4 
PDLSCS 0 0 
In trial group 66 % women delivered full term vaginally, but in Control group 42% women delivered 
full term vaginally. 
Biochemical Estimation 
Table 27: LCPUFA Levels at the end of 9th month 
Fatty Acids (g/100g fatty Acids) 
Groups LA ALA AA DHA 
Control 31.64 0.43 6.7 0.45 
Trial 31.83 0.49 7.38 0.47 
The difference between LCPUFA levels of both trial & control groups is not significant. 
Table 28: MDA Levels at the end of 9th month 
Group MDA (nmols/ml) 
Control 12.85 
Trial 12.73 
The difference between MDA levels of both trial & control groups is not significant. 
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Table 29: Placental LCPUFA Levels 
Fatty Acids(g/100g fatty Acids) 
Groups LA ALA AA DHA 
Control 30.46 0.32 6.95 0.52 
Trial 29.79 0.48 5.71 0.5 
The difference between Placental LCPUFA levels of both trial & control groups is not significant. 




The difference between Placental MDA levels of both 
trial & control groups is not significant, 8 volunteers 
from trial group needed induction (dionoprostone) 
had cervical ripening and favorable Bishop's score (> 
6) and position of cervix was anterior and 
consistency was soft. None of them needed 
augmentation. All delivered normally and total 
labour duration was less than 12 hrs. The volunteers 
from control group those needed induction with 
cerviprime (dionoprostone gel) were 26 had cervix 
posterior and consistency was firm, 4 had cervix mid 
posterior and consistency was medium, 1 had cervix 
posterior and consistency was medium.16 of them 
required LSCS, 9 had normal delivery but needed 
augmentation with oxytocin drip and labour duration 
was more than 12 hrs. Only 1 needed no intervention 
with drugs. Thus for labour onset on proper time 
cervical ripening is necessary, which is achieved by 
Anuvasan basti causing local oleation and softening of 
cervix and perineum. Again this is due to 
maintenance of normal functioning of Vata.  
Table 31: Distribution according to need of 
augmentation 
Need of augmentation % Yes No 
Trial 24 76 
Control 80 20 
In trial group only 24% volunteers needed 
augmentation out of which only 4 volunteers needed 
L.S.C.S. In control group 80% volunteers needed 
augmentation, out of which 18 volunteers needed 
L.S.C.S. due to uterine inertia. The uterine inertia 
results in delay in cervical dilatation, prolonged 
labour, foetal distress and hence is unfavorable for 
normal labour. In trial group very few volunteers 
needed augmentation with oxytocin in minimal 
dosage. 
Table 32: Distribution according to Partogram 
curve 
Partogram Curve% Abnormal Normal 
Trial 26 74 
Control 72 28 
In trial group only 13 volunteers had 
abnormal partogram curve. As the progress of labor 
depends on cervical dilatation, effacement, uterine 
contractions, foetal descent and bearing down efforts 
etc both Basti help keep all factors in balanced state 
favoring normal labour. Thus this treatment is said to 
be highly effective in normal labour in every aspect. 
Table 33: Distribution according to total duration 
of labour 






Trial 12 88 
Control 64 36 
Table 34: Increase in Weight of the patients 
Average increase in maternal Weight (kgs). 
Trial 3.83 
Control 3.07 
This table shows that average maternal 
weight gain in 8th & 9th months from trial group was 
significantly more than that of control group. This is 
due to optimal nutrition provided by Yavagu, which 
is a rich source of proteins (essential amino acids) & 
PUFA showing high rate of absorption. 
Table 35: Incidence of Increase in Fetal Weight 
Average increase in Fetal Weight (gm). 
Trial 1833.78 
Control 1532.40 
This table shows that average foetal weight 
gain in 8th & 9th months from trial group was 
significantly more than that of control group. Fetus 
gains maximum weight (approx. 1.5-2kg) in the last 
trimester of pregnancy. This is again due to optimal 
nutrition provided by Yavagu, which is a rich source 
of proteins (essential amino acids) and PUFA 
showing high rate of absorption and transfer to fetus 
by placenta. 
Table 36: Birth Weight 
Average Birth Weight in gm. 
Trial 3158.80 
Control 2712.00 
This chart shows a significant difference 
between the average birth weights of both groups. 
Trial group shows nearly 400gm more weight than 
control group. We would like to credit this difference 
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to the virtues of Yavagu, which again has proved to 
be a perfect dietary regimen especially in later 
months of pregnancy. 
Table 37: Distribution according to Mode of 
Delivery 
Mode of Delivery in % Trial Control 
FTND 66 42 
PTVD 6 6 
PDVD 0 0 
LSCS 28 48 
PTLSCS 0 4 
PDLSCS 0 0 
According to WHO, only 63% primipara 
patient deliver normally without any invasion and 
have spontaneous onset. In trial group 66% FTNDs & 
6% PTNDs (total 72%) were seen; only 14 volunteers 
out of 50 (28%) needed L.S.C.S. But in Control group 
only 42% women delivered full term vaginally 
whereas 48% needed L.S.C.S. So there is high 
incidence of normal delivery in trial group. The 
volunteers who needed L.S.C.S. also had good cervical 
effacement, dilatation and effective uterine 
contractions. Indications for L.S.C.S. were different 
from cervical dystocia. Nowadays cervical dystocia is 
considered as leading cause for invasive labour. 
However we were able to overcome the cervical 
factor.  
Other beneficial effects of Anuvasana basti 
120ml is the Matra of Anuvasan basti. Anuvasan basti 
had many benefits as follows: 
1. One volunteer had less foetal movements, but 
after 2-3 Basti, she had marked foetal 
movements. 
2. No side effects / complications of Anuvasan basti 
were noted. Many volunteers had soft stools, no 
one had constipation. 
3. 2 volunteers had dribbling micturation which 
recovered satisfactorily after Anuvasan basti. 
Thus the treatment was effective in terms of 
reproductive performance and did not cause any 
untoward side effects which would be hazardous to 
maternal or foetal health. 
Concept of cleansing of intestine and retention of 
basti 
Basti may cleanse some part of the intestine 
by repeated evacuation. Whole intestine is covered 
by 4 layers i.e., muscular, sub mucosa, serous and 
mucosal layer. Basti dravya comes in contact with 
mucosal layer which is superficially situated. When 
the intestine get purified daily the layer of intestine 
and villi get the nutrition and further absorption of 
micronutrients may be enhanced and these 
micronutrients may enter the circulation and finally 
it reaches the target organ. As Basti which is given in 
minimal quantity, retain for longer time. So the drug 
will act locally or systemically after the absorption 
through the mucous membrane of the rectum. The 
rectum contains minute vein, the mucous membrane 
of the intestine can easily absorb the lipid soluble 
content. Finally it reaches to circulation, thus drug 
may get delivered to the target organ. According to 
modern science, there is no digestive action of fat or 
oil in stomach. The fat digestion and absorption takes 
place in large intestine. Basti drugs contain Sneha 
Dravya in sufficient quantity, when it is introduced 
through the rectum it gets easily absorbed in large 
intestine. Best and Tayler have mentioned that 
“materials introduced by Enema, in some instances 
pass through the walls into the ileum; such 
incompetence may permit the enema fluid to reach 
the duodenum”. Also the possibility of materials from 
even the lower bowel, reaching the stomach is 
strongly suggested by the fact that lycopodium 
spores introduced into the colon by enema have been 
recovered some hours later from washing of the 
stomach. Dwarkanatha suggested that “Basti therapy 
by various of its medicaments greatly influences the 
normal bacterial flora of the colon.” By doing so it 
modulates the rate of endogenous synthesis of 
vitamin B12 which is normally manufactured by 
colonicerial flora. This vitamin B12 may have a role 
to play in the maintenance or regeneration of nerves. 
According to him it was one of the possible 
mechanism through which Basti could help in Vatika 
or Neurological diseases. 
Role of Basti 
1. Basti therapy by various of its medicaments 
greatly influences the normal bacterial flora of 
the colon. By doing so it modulates the rate of 
endogenous synthesis of vitamin B12. 
2. This vitamin B12 may have a role to play in the 
maintenance or regeneration of nerves. It was 
one of the possible mechanism through which 
Basti could help in Vatika or Neurological 
diseases. 
However no significant difference was found 
in the LCPUFA levels between both groups. But 
beneficial effects of local (Basti/Enemata) and 
internal (Yavagu) treatments are hard to ignore. This 
effect can be attributed to high quality of protein 
source (Yavagu) as well as regulation of Vata by 
Basti, which helped enhance the overall reproductive 
performance. Further extensive research is needed to 
prove the role of LCPUFA in improving the birth 
CONCLUSION 
The clinical study was done for evaluation of 
efficacy of Antenatal management in Ayurveda 
during 8th & 9th month of pregnancy. Bala taila is 
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highly effective to bring about spontaneous labour 
onset at optimal time. It causes more than 1cm 
dilatation per hour & thus labour progress was 
within optimal time. Duration of labour was reduced 
by Bala siddha taila basti due to its regulation of 
Prasuti Marut. 
Invasive delivery (Forcep / ventouse) rate is 
reduced and Partogram that reflects progress of 
labour is normal due to Bala siddha taila basti. 
Maternal and foetal complications during Ante natal 
and post natal period are reduced due to Bala siddha 
taila Anuvasan basti, Niruha basti & due to high 
quality nutritive supplementation (Mudga & Masha 
Yavagu). Maternal complaints like constipation, 
backache, lower abdominal pain are relieved and 
patient remains comfortable due to Niruha basti. Bala 
siddha taila Anuvasan basti & Niruha basti ensures 
easy, uneventful labour. The Ayurvedic regimen has 
promise of providing the optimal and balanced 
nutrition by using quality ingredients. 
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